Colorcon sets up $50m venture fund for promising pharma companies

The fund is focused on start-ups that are strategically relevant to the core Colorcon business of advanced coating systems, modified release technologies and functional excipients

picture of

Breaking News

Mesa Labs acquires Gyros Protein Technologies

The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin ...

GVK Bio reveals whether research or development services perform better

The global contract research and development organisation compares and explains levels of growth in its business ...

XPhyto Therapeutics inks distribution deal with cannabis grower

The supplier is an international grower and extractor with ongoing EU GMP certification for high THC flower and outdoor ...

What happens if a company doesn’t have any records of its R&D activities?

Companies in the UK engaged in R&D can get up to 33% of innovation expenditures back. Myriad Associates explains how to ...

Vifor Pharma enters commercial diabetes collaboration in the US

The Swiss pharma company will work with US-based Janssen to jointly commercialise INVOKANA (canagliflozin) in the US to ...

Bio-Techne to invest up to $50m for GMP protein production facility

E. coli-derived recombinant proteins are an essential component for many bioprocessing and cell therapy manufacturing ...

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market

Cesca Therapeutics changes name to match new focus

The newly named ThermoGenesis has moved from automated cell separation and cryostorage technologies into cell ...

SP Industries expands global presence with Spanish i-Dositecno acquisition

The US-based fill-finish specialist's acquisition of the sterile filling lines provider is the next step following a ...

An automatic response to businesses’ financial woes

The UK business world is in crisis. It might sound like an over-dramatic statement; however, from a financial ...

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost- ...

Bringing flexibility to pharmaceutical manufacturing

With the spectacular four-year bull run of pharmaceutical and biotech valuations from 2011-2015 over, manufacturers ...

The European Investment Bank loans Polish biotech $33m for growth

Blood cancer-focused Mabion will use the financing for its R&D programme, conducting clinical trials, as well as ...

Germany leads the European pharmaceutical industry

The German nation consolidates its status as an elite economy in the CPhI Pharma Index 2019